Communication with the clinic for Multiple Sclerosis

Johns Hopkins University, Baltimore, MD
Multiple SclerosisCommunication with the clinic - Other
All Sexes
What conditions do you have?

Study Summary

This trial will help create a questionnaire to confirm relapses in MS patients and study if communication with providers improves patient care.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 96 weeks

96 weeks

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Active Control

Experimental Treatment

150 Total Participants · 2 Treatment Groups

Primary Treatment: Communication with the clinic · No Placebo Group · N/A

Experimental Group · 1 Intervention: Communication with the clinic · Intervention Types: Other
ActiveComparator Group · 1 Intervention: Communication with the clinic · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 96 weeks

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,115 Previous Clinical Trials
32,578,619 Total Patients Enrolled
28 Trials studying Multiple Sclerosis
2,366 Patients Enrolled for Multiple Sclerosis
Ellen MowryPrincipal InvestigatorJohns Hopkins University

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be able to speak English.
You are currently beginning treatment with certain medications for multiple sclerosis, including injections or oral medications.
You have a type of multiple sclerosis called relapsing-remitting MS, which was diagnosed based on specific criteria from 2010.
You have a disability level of 6.0 or less according to the Expanded Disability Status Scale (EDSS).

Frequently Asked Questions

To what extent is this research trial recruiting participants?

"Affirmative. The information hosted on establishes that this medical experiment, which was initially posted on July 31st 2018 is currently recruiting patients. 150 participants must be recruited from a single study site." - Anonymous Online Contributor

Unverified Answer

Is it still possible to participate in this research endeavor?

"Affirmative. On, it is noted that this examination commenced its recruitment of participants on July 31st 2018 and was last modified on May 5th 2022. The trial aims to enlist 150 individuals from a single medical location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.